
S7E2: Cancer Without Borders: Backing the Best Science
What if the next breakthrough cancer medicine came from a lab halfway around the world?
Discover how scientists, doctors, and investors are looking across borders to bring new cancer treatments to patients. From therapies that reprogram a patient’s own immune cells to medicines that build on discoveries made across continents, this episode explores how global science and capital are expanding what’s possible in cancer care—and the work required to turn promising research into treatments patients can trust and access.
Guests include:
- John Oyler, Co-Founder and CEO of BeOne Medicines
- Dr. Elizabeth O’Donnell, Medical Oncologist and Director of the Multi-Cancer Early Detection Clinic at Dana-Farber Cancer Institute (CA client)
- Jamie Topper, Managing Partner at Frazier Life Sciences
- Judy Zhang, Partner at Cambridge Associates
Cambridge Conversations and Unseen Upside are developed in partnership with PRX, an award-winning podcast media company.
Cambridge Associates is a global investment firm that works with endowments, foundations, healthcare systems, pension plans, and private clients to implement and manage custom investment portfolios that aim to generate outperformance and maximize their impact on the world. Cambridge Associates delivers a range of portfolio management services, including outsourced CIO, non-discretionary portfolio management, staff extension, and asset class mandates.
Flere episoder fra "Unseen Upside: Investments Beyond Their Returns"



Gå ikke glip af nogen episoder af “Unseen Upside: Investments Beyond Their Returns” - abonnér på podcasten med gratisapp GetPodcast.








